Dr. Jane E. Lim, MD

Dr. Lim practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Lim's NPI, 1952797193, was assigned on April 14, 2015. Dr. Lim graduated from George Washington University School of Medicine and Health Sciences in 2015. Dr. Lim holds California license A147236.

Dr. Lim's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Lim's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Lim to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lim practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lim's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lim is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Lim is licensed in California.

Dmand AI lists irritable bowel syndrome (IBS) among the conditions Dr. Lim treats.

CMS data shows 552 Medicare services from Dr. Lim across 14 procedure codes in 2024, for 283 Medicare patients. Medicare paid $28,238 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 283 Medicare patients who saw Dr. Lim in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lim's median patient age at 61, with 68% women.

In 2024, Dr. Lim wrote 272 Medicare Part D claims for 56 patients. 47% of them were for generic drugs. CMS names the drug for 184 of them, across 9 drugs with 11 or more claims each, at $134,094 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Lim for performance year 2024, reported as part of a group. Dr. Lim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lim as offering telehealth. CMS counts 30 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lim, more than 55% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Lim, published from 2016 to 2024. 2023 was the busiest year, with 2. Dr. Lim has published most often in Dig Dis Sci. Dr. Lim's most frequent co-authors are Ali Rezaie, Alagappan Anand Annamalai, MD and Debra Ann Benator, MD.

CMS Open Payments shows 7 general payments to Dr. Lim from 6 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $123.

Dmand AI lists 5 awards for Dr. Lim, most recently Resident of the Year in 2018. Dr. Lim serves on Texas Society of Gastroenterology and Endoscopy.

Dr. Lim graduated from George Washington University School of Medicine and Health Sciences in 2015. Dr. Lim is a member of ACG, AGA, American Neurogastroenterology and Motility Society and ASGE.

Dr. Lim is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.